Mr. James V. Finch, NP Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 520 W Santa Monica Ave, Dededo, GU 96929 Phone: 671-635-7492 Fax: 671-635-7493 |
Mrs. Cathleen A. Distor, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 548 South Marine Corps Drive, Tamuning, GU 96913 Phone: 671-646-5824 Fax: 671-647-3546 |
Ms. Jeanelle Martinez, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 472 Chalan San Antonio, Pemar Place, Tamuning, GU 96913 Phone: 671-647-1830 Fax: 671-647-1919 |
Monica Webb, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 472 Chalan San Antonio, Tamuning, GU 96913 Phone: 671-647-1830 |
Mrs. Christina Joy Anciano, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 472 Chalan San Antonio, Tamuning, GU 96913 Phone: 671-300-6310 Fax: 671-647-1919 |
Kathryn May Cooper, Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 472 Chalan San Antonio, Tamuning, GU 96913 Phone: 671-300-6310 Fax: 671-647-1919 |
News Archive
It was good news that the Obama administration withstood pressure from Roman Catholic bishops and social conservatives to deny contraceptive coverage for millions of American women who work for religiously affiliated employers. Kathleen Sebelius, the Health and Human Services secretary, rejected broad exemptions from a new rule requiring all health plans to cover birth control, without a deductible or co-payment.
UC San Francisco physician-scientists have developed a test that can predict how patients with juvenile myelomonocytic leukemia (JMML) will respond to treatment, and may also be able to identify patients who are likely to recover spontaneously with little to no treatment.
Aromatase inhibitor-associated arthralgia (AIAA) is a major side effect in breast cancer survivors, producing joint pain so severe that as many as ten percent of women discontinue their therapy prematurely while undergoing treatment with these lifesaving drugs.
The age-standardized mortality rate for hemorrhagic stroke has decreased worldwide over the past two decades, but incidence, number of deaths, and lost disability-adjusted life-years continue to increase. While hemorrhagic stroke occurs half as frequently globally as ischemic stroke, it causes significantly more deaths and lost DALY.
Novo Nordisk Inc., a global healthcare company and leader in diabetes care, today announced the second issue of the Novo Nordisk BlueSheet, a resource for information on diabetes and chronic disease, highlighting key issues in diabetes prevention, detection, treatment and care.
› Verified 3 days ago